Correlation Between Apellis Pharmaceuticals and Roivant Sciences
Can any of the company-specific risk be diversified away by investing in both Apellis Pharmaceuticals and Roivant Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apellis Pharmaceuticals and Roivant Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apellis Pharmaceuticals and Roivant Sciences, you can compare the effects of market volatilities on Apellis Pharmaceuticals and Roivant Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apellis Pharmaceuticals with a short position of Roivant Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apellis Pharmaceuticals and Roivant Sciences.
Diversification Opportunities for Apellis Pharmaceuticals and Roivant Sciences
0.6 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Apellis and Roivant is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Apellis Pharmaceuticals and Roivant Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Roivant Sciences and Apellis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apellis Pharmaceuticals are associated (or correlated) with Roivant Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Roivant Sciences has no effect on the direction of Apellis Pharmaceuticals i.e., Apellis Pharmaceuticals and Roivant Sciences go up and down completely randomly.
Pair Corralation between Apellis Pharmaceuticals and Roivant Sciences
Given the investment horizon of 90 days Apellis Pharmaceuticals is expected to generate 1.95 times more return on investment than Roivant Sciences. However, Apellis Pharmaceuticals is 1.95 times more volatile than Roivant Sciences. It trades about 0.19 of its potential returns per unit of risk. Roivant Sciences is currently generating about 0.12 per unit of risk. If you would invest 2,734 in Apellis Pharmaceuticals on August 28, 2024 and sell it today you would earn a total of 457.00 from holding Apellis Pharmaceuticals or generate 16.72% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Apellis Pharmaceuticals vs. Roivant Sciences
Performance |
| Timeline |
| Apellis Pharmaceuticals |
| Roivant Sciences |
Apellis Pharmaceuticals and Roivant Sciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Apellis Pharmaceuticals and Roivant Sciences
The main advantage of trading using opposite Apellis Pharmaceuticals and Roivant Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apellis Pharmaceuticals position performs unexpectedly, Roivant Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Roivant Sciences will offset losses from the drop in Roivant Sciences' long position.| Apellis Pharmaceuticals vs. Eliem Therapeutics | Apellis Pharmaceuticals vs. HCW Biologics | Apellis Pharmaceuticals vs. Scpharmaceuticals | Apellis Pharmaceuticals vs. Milestone Pharmaceuticals |
| Roivant Sciences vs. Eliem Therapeutics | Roivant Sciences vs. HCW Biologics | Roivant Sciences vs. Scpharmaceuticals | Roivant Sciences vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Transaction History View history of all your transactions and understand their impact on performance | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |